Companies › STOK

STOKE THERAPEUTICS INC (STOK)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001623526 · EDGAR filings · Updated 2026-07-17

STOKE THERAPEUTICS INC (STOK) has reported institutional ownership of 114.2%, with 197 institutional managers holding positions valued at $2.31B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Initial insider ownership filed (Form 3)
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)
• 2026-06-30 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, STOKE THERAPEUTICS INC has 197 institutional holders and institutional ownership of 114.2%.

Insider activity

Insiders reported 116 transactions (0 buys, 87 sells) across 9 reporting insiders, with a net reported value of −$43.0M.

Data flags from SEC filings

Related companies

LIFESTANCE HEALTH GROUP INC (LFST) · SYNDAX PHARMACEUTICALS INC (SNDX) · LIQUIDIA CORPORATION COM NEW (LQDA) · CELLDEX THERAPEUTICS INC NEW (CLDX) · WARBY PARKER INC CL A COM (WRBY) · SUMMIT THERAPEUTICS INC (SMMT)